(Q45601776)

English

HLA class I serotypes and cytotoxic T-lymphocyte responses among human immunodeficiency virus-1-uninfected Thai volunteers immunized with ALVAC-HIV in combination with monomeric gp120 or oligomeric gp160 protein boosting

scientific article published in September 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

HLA class I serotypes and cytotoxic T-lymphocyte responses among human immunodeficiency virus-1-uninfected Thai volunteers immunized with ALVAC-HIV in combination with monomeric gp120 or oligomeric gp160 protein boosting (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

0 references

0 references

Deborah L. Birx

15

object named as

Birx DL

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Paris R

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Bejrachandra S

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Karnasuta C

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Chandanayingyong D

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Kunachiwa W

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Leetrakool N

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Prakalapakorn S

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Thongcharoen P

8

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Nittayaphan S

9

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Pitisuttithum P

10

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Suriyanon V

11

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Gurunathan S

12

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

McNeil JG

13

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Brown AE

14

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

de Souza M

16

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Tissue Antigens

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

64

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

251-256

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2004.00270.X

21 January 2018

Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2004.00270.X

21 January 2018

Advantage of rare HLA supertype in HIV disease progression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2004.00270.X

21 January 2018

Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2004.00270.X

21 January 2018

Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2004.00270.X

21 January 2018

Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2004.00270.X

21 January 2018

A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2004.00270.X

21 January 2018

A Naturally Selected Dimorphism within the HLA-B44 Supertype Alters Class I Structure, Peptide Repertoire, and T Cell Recognition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2004.00270.X

21 January 2018

Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2004.00270.X

21 January 2018

Immunogenicity of a recombinant human immunodeficiency virus (HIV)-canarypox vaccine in HIV-seronegative Ugandan volunteers: results of the HIV Network for Prevention Trials 007 Vaccine Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2004.00270.X

21 January 2018

Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2004.00270.X

21 January 2018

HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2004.00270.X

21 January 2018

Identifiers

10.1111/J.1399-0039.2004.00270.X

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45601776&oldid=2077429876"